Synonyms: R-1450 | RG-1450 | Ro-4909832
Compound class:
Antibody
Comment: Gantenerumab targets aggregated forms of human amyloid β (Aβ) proteins Aβ42 and Aβ40. This is in contrast to solanezumab which targets soluble Aβ.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein sequence analysis reveals that gantenerumab is likely to be clone #7.9.H7 in patent US7794719 [1]. |
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
8894 | gantenerumab |
Synonyms |
R-1450 | RG-1450 | Ro-4909832 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 223 |
Other databases | |
GtoPdb PubChem SID | 178103515 |
PubChem SID | 178103515 |
Search PubMed clinical trials | gantenerumab |
Search PubMed titles | gantenerumab |
Search PubMed titles/abstracts | gantenerumab |
Wikipedia | Gantenerumab |